No headlines found.
No press releases found.
No news found.
The Innovator Premium Income Buffer ETF is designed to provide investment performance for each Outcome Period that is equal to the Defined Distribution Rate, while providing a buffer against the first of SPDR S&P ETF Trust (SPY) losses over each -month outcome period. The Fund invests in FLexible EXchange Options ("FLEX Options") that reference the SPDR S&P 500 ETF Trust (the "Underlying ETF") and U.S. Treasury bills ("U.S. Treasuries") to employ an income-oriented "defined outcome strategy." Defined outcome strategies seek to produce pre-determined investment outcomes based upon the performance of an underlying security or index. The outcomes sought by the Fund, which include the defined distributions and buffer discussed below (the "Outcomes"), are contingent on the performance of the Underlying ETF's price return and the yield of the U.S. Treasuries over an approximately one-year period from April 1 through March 31 of the following year (the "Outcome Period"). The current Outcome Period is from April 1, 2024 through March 31, 2025.
SHL Telemedicine Innovator Premium Income 9 Buffer ETF - April trades on the BATS stock market under the symbol HAPR.
As of May 8, 2024, HAPR stock price was flat at $24.92 with million shares trading.
HAPR has a market cap of $1.25 million. This is considered a Sub-Micro Cap stock.
HAPR support price is $24.87 and resistance is $24.99 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HAPR stock will trade within this expected range on the day.